Marina G. Moschetta

Sao Jose Do Rio Preto, SP 15090000, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Prognostic phenotypic classification for canine mammary tumors.

Prognostic phenotypic classification for canine mammary tumors.

Journal: Oncology letters

Published: July 03, 2018

Evaluation of Angiogenesis Process after Metformin and LY294002 Treatment in Mammary Tumor.

Evaluation of Angiogenesis Process after Metformin and LY294002 Treatment in Mammary Tumor.

Journal: Anti-cancer agents in medicinal chemistry

Published: April 24, 2018

Melatonin Differentially Modulates NF-кB Expression in Breast and Liver Cancer Cells.

Melatonin Differentially Modulates NF-кB Expression in Breast and Liver Cancer Cells.

Journal: Anti-cancer agents in medicinal chemistry

Published: August 10, 2017

Efficacy of melatonin, IL-25 and siIL-17B in tumorigenesis-associated properties of breast cancer cell lines.

Efficacy of melatonin, IL-25 and siIL-17B in tumorigenesis-associated properties of breast cancer cell lines.

Journal: Life sciences

Published: March 20, 2017

Melatonin and IL-25 modulate apoptosis and angiogenesis mediators in metastatic (CF-41) and non-metastatic (CMT-U229) canine mammary tumour cells.

Melatonin and IL-25 modulate apoptosis and angiogenesis mediators in metastatic (CF-41) and non-metastatic (CMT-U229) canine mammary tumour cells.

Journal: Veterinary and comparative oncology

Published: August 19, 2016

Inhibition of Epithelial-mesenchymal Transition in Response to Treatment with Metformin and Y27632 in Breast Cancer Cell Lines.

Inhibition of Epithelial-mesenchymal Transition in Response to Treatment with Metformin and Y27632 in Breast Cancer Cell Lines.

Journal: Anti-cancer agents in medicinal chemistry

Published: May 17, 2016

Inhibition of Epithelial-Mesenchymal Transition and Metastasis by Combined TGFbeta Knockdown and Metformin Treatment in a Canine Mammary Cancer Xenograft Model.

Inhibition of Epithelial-Mesenchymal Transition and Metastasis by Combined TGFbeta Knockdown and Metformin Treatment in a Canine Mammary Cancer Xenograft Model.

Journal: Journal of mammary gland biology and neoplasia

Published: January 22, 2016

Melatonin Regulates Angiogenic and Inflammatory Proteins in MDA-MB-231 Cell Line and in Co-culture with Cancer-associated Fibroblasts.

Melatonin Regulates Angiogenic and Inflammatory Proteins in MDA-MB-231 Cell Line and in Co-culture with Cancer-associated Fibroblasts.

Journal: Anti-cancer agents in medicinal chemistry

Published: December 12, 2015

Proinflammatory and Anti-Inflammatory Cytokines Mediated by NF-κB Factor as Prognostic Markers in Mammary Tumors.

Proinflammatory and Anti-Inflammatory Cytokines Mediated by NF-κB Factor as Prognostic Markers in Mammary Tumors.

Journal: Mediators of inflammation

Published: October 26, 2015

Effect of Melatonin in Epithelial Mesenchymal Transition Markers and Invasive Properties of Breast Cancer Stem Cells of Canine and Human Cell Lines.

Effect of Melatonin in Epithelial Mesenchymal Transition Markers and Invasive Properties of Breast Cancer Stem Cells of Canine and Human Cell Lines.

Journal: PloS one

Published: July 14, 2015

Melatonin decreases breast cancer metastasis by modulating Rho-associated kinase protein-1 expression.

Melatonin decreases breast cancer metastasis by modulating Rho-associated kinase protein-1 expression.

Journal: Journal of pineal research

Published: June 29, 2015

Melatonin Regulates Angiogenic Factors under Hypoxia in Breast Cancer Cell Lines.

Melatonin Regulates Angiogenic Factors under Hypoxia in Breast Cancer Cell Lines.

Journal: Anti-cancer agents in medicinal chemistry

Published: November 28, 2014

Showing 1-12 of 20

Last Updated: 09/26/2026